Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 1;23(2):115-116.
doi: 10.1097/CND.0000000000000383.

Clinical Variant of Guillain-Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine

Anca Badoiu  1 , Olivier Moranne  2 , Sarah Coudray  3 , Ioana Maria Ion  1
Affiliations

Clinical Variant of Guillain-Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine

Anca Badoiu et al. J Clin Neuromuscul Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

References

    1. Susuki K, Koga M, Hirata K, et al. A Guillain-Barré syndrome variant with prominent facial diplegia. J Neurol. 2009;256:1899–1905.
    1. MHRA Guidance on Coronavirus (COVID-19). Available at: https://www.gov.uk/government/collections/mhra-guidance-on-coronavirus-c... . Accessed May 28, 2021.
    1. Badoiu A, Thouvenot E, Coudray S, et al. Deux cas consécutifs de syndrome de Guillain–Barré avec diplégie faciale dans le contexte d'infection avec le virus SARS-CoV-2. Revue Neurologique. 2021;177:S69.
    1. Costello F, Dalakas MC. Cranial neuropathies and COVID-19. Neurology. 2020;95:195.
    1. Lucchese G, Flöel A. SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress and Chaperones. 2020;25:731–735.